Vivo Capital, LLC Q4 2019 Filing
Filed February 13, 2020
Portfolio Value
$1.4T
Holdings
4
Report Date
Q4 2019
Filing Type
13F-HR
All Holdings (4 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —Ascendis Pharma A/S | 2,060,135 | $286.6B | 21.18% | |
| 2 | —New Frontier Health Corp | 14,300,000 | $143.0B | 10.57% | |
| 3 | —Aurinia Pharmaceuticals Inc. | 5,471,458 | $110.9B | 8.19% | |
| 4 | —Crinetics Pharmaceuticals Inc | 3,375,169 | $84.7B | 6.26% | |
| 5 | —Zymeworks Inc | 1,482,519 | $67.4B | 4.98% | |
| 6 | —Kadmon Holdings Inc | 13,930,134 | $63.1B | 4.66% | |
| 7 | —Arrowhead Pharmaceuticals Inc | 674,376 | $42.8B | 3.16% | |
| 8 | —Sinovac Biotech Ltd. | 5,900,000 | $38.2B | 2.82% | |
| 9 | —Constellation Pharmaceutical | 738,235 | $34.8B | 2.57% | |
| 10 | —Iovance Biotherapeutics, Inc. | 1,219,707 | $33.8B | 2.49% | |
| 11 | —Codexis, Inc | 1,834,099 | $29.3B | 2.17% | |
| 12 | —Insmed Inc | 1,208,495 | $28.9B | 2.13% | |
| 13 | —Tricida, Inc. | 763,936 | $28.8B | 2.13% | |
| 14 | —Eiger BioPharmaceuticals Inc | 1,791,257 | $26.7B | 1.97% | |
| 15 | —KalVista Pharmaceuticals Inc. | 1,476,796 | $26.3B | 1.94% | |
| 16 | —MEI Pharma Inc | 10,164,328 | $25.2B | 1.86% | |
| 17 | —Amyris, Inc | 6,491,580 | $20.1B | 1.48% | |
| 18 | —Menlo Therapeutics Inc. | 4,011,236 | $18.6B | 1.38% | |
| 19 | —Orchard Therapeutics plc | 1,312,084 | $18.0B | 1.33% | |
| 20 | —Rocket Pharmaceuticals Inc | 786,712 | $17.9B | 1.32% | |
| 21 | —Mirati Therapeutics Inc. | 135,545 | $17.5B | 1.29% | |
| 22 | —Forty Seven Inc | 414,792 | $16.3B | 1.21% | |
| 23 | —Matinas Biopharma Hldgs Inc | 6,818,181 | $15.5B | 1.14% | |
| 24 | —Avrobio Inc | 701,832 | $14.1B | 1.04% | |
| 25 | —Dermira Inc | 914,961 | $13.9B | 1.02% | |
| 26 | —Homology Medicines, Inc. | 607,555 | $12.6B | 0.93% | |
| 27 | —Apellis Pharmaceuticals, Inc. | 383,538 | $11.7B | 0.87% | |
| 28 | —Xenon Pharmaceuticals Inc | 881,310 | $11.6B | 0.85% | |
| 29 | —IGM Biosciences Inc | 288,468 | $11.0B | 0.81% | |
| 30 | —Kiniksa Pharmaceuticals | 843,478 | $9.3B | 0.69% | |
| 31 | —Zai Lab Limited | 222,107 | $9.2B | 0.68% | |
| 32 | —Verona Pharma PLC | 1,492,951 | $8.6B | 0.63% | |
| 33 | —Soleno Therapeutics, Inc. | 2,168,959 | $6.4B | 0.47% | |
| 34 | —Chiasma Inc | 1,272,156 | $6.3B | 0.47% | |
| 35 | —Karuna Therapeutics Inc | 74,320 | $5.6B | 0.41% | |
| 36 | —Galmed Pharmaceuticals Ltd | 955,670 | $5.5B | 0.41% | |
| 37 | —Zogenix Inc | 105,000 | $5.5B | 0.40% | |
| 38 | —Collegium Pharmaceutical Inc | 211,529 | $4.4B | 0.32% | |
| 39 | —Kala Pharmaceuticals, Inc. | 1,043,020 | $3.8B | 0.28% | |
| 40 | —Nabriva Therapeutics AG | 2,754,486 | $3.6B | 0.27% | |
| 41 | —Aclaris Therapeutics, Inc. | 1,647,214 | $3.1B | 0.23% | |
| 42 | —DBV Technologies S.A. | 269,995 | $2.9B | 0.21% | |
| 43 | —Cymabay Therapeutics Inc | 1,077,467 | $2.1B | 0.16% | |
| 44 | —Atricure Inc | 64,573 | $2.1B | 0.16% | |
| 45 | —Precision Biosciences Inc | 140,255 | $1.9B | 0.14% | |
| 46 | —Selecta Biosciences Inc | 546,054 | $1.3B | 0.10% | |
| 47 | —Genocea Biosciences Inc | 626,401 | $1.3B | 0.10% | |
| 48 | —Sierra Oncology, Inc | 2,438,270 | $835.0M | 0.06% | |
| 49 | —Agile Therapeutics, Inc. | 189,247 | $473.0M | 0.03% |